Novartis Pharmaceuticals Corporation v. Plexxikon Inc. > Summary
Court Case Number IPR2018-01287
Filing Date Jun 18, 2018
Court Patent Trial and Appeal Board
Status Terminated-Denied
Administrative JudgesJo-Anne M. Kokoski, Sheridan K. Snedden, Kristi L. R. Sawert
Judge Writing the Final DecisionJo-Anne M. Kokoski
Claims Challenged in the Petition: 1, 2, 4, 5, 6, 9, 11, 12
Claims Instituted: 1, 2, 4, 5, 6, 9, 11, 12
Petitioner
Patent Owner
Petitioner Attorneys
2Novartis
Attorney Name: Akira Suzuki
Novartis
Novartis
Attorney Name: Phillippe Baran
McDermott Will & Emery
Patent Owner Attorneys
11Novartis
Attorney Name: Robert H. Underwood
McDermott Will & Emery
Plexxikon
Attorney Name: Brian C. Chang
Weil, Gotshal & Manges
Plexxikon
Attorney Name: Derek C. Walter
Weil, Gotshal & Manges
Plexxikon
Attorney Name: Elizabeth S. Weiswasser
Weil, Gotshal & Manges
Novartis
Attorney Name: Thomas P. Steindler
McDermott Will & Emery
Plexxikon
Attorney Name: Timothy J. Andersen
Weil, Gotshal & Manges
Novartis
Attorney Name: Andrew R. Basile Jr.
Young Basile Hanlon & MacFarlane P.C.
Novartis
Attorney Name: Andrew R. Basile
Young Basile Hanlon & MacFarlane P.C.
Novartis
Attorney Name: Jeffrey D. Wilson
Young Basile Hanlon & MacFarlane P.C.
Novartis
Attorney Name: Ryan T. McCleary
Young Basile Hanlon & MacFarlane P.C.
Plexxikon
Attorney Name: Andrew R. Basile Jr.
Young Basile Hanlon & MacFarlane P.C.
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09469640 | Compounds and methods for kinase modulation, and indications therefor | Oct 18, 2016 |
